A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis.

Frontiers in oncology(2021)

引用 1|浏览4
暂无评分
摘要
The addition of IC followed by dCCRT for patients with ESCC might be associated with better PFS rates based on a clinical scoring model but has no impact on OS rates. Further prospective studies are warranted for the validation of this model.
更多
查看译文
关键词
definitive concurrent chemoradiotherapy,esophageal squamous cell carcinoma,induction chemotherapy,overall survival,progression-free survival
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要